Cambridge Psychedelic Research Group (CPRG)
The Cambridge Psychedelic Research Group is a multidisciplinary team of world-renowned scientists and clinicians focused on investigating the therapeutic potential of psychedelics, empathogens, and dissociatives for the treatment of mental illness.
About The Cambridge Psychedelic Research Group
The Cambridge Psychedelic Research Group, led by Dr. Liliana Galindo, is a multidisciplinary team of psychiatrists, clinical psychologists, nurse practitioners, pharmacologists, and researchers from Cambridgeshire and Peterborough NHS Foundation Trust, Cambridge University Hospitals, and the University of Cambridge. The group brings together diverse skills and expertise to study the therapeutic potential of psychedelics, empathogens, and dissociatives for a range of mental health conditions, including major depression, PTSD, and eating disorders. Their mission is to advance the science and clinical practice of psychedelic therapy through community-based research, international collaborations, and academic-industry partnerships. Through this work, the group aims to inform evidence-based practices and sensible drug policy to transform mental healthcare for all.
The Cambridge Psychedelic Research Group is located in the Department of Psychiatry within the School of Clinical Medicine at the University of Cambridge.
Introduce your brand
Take a minute to write an introduction that is short, sweet, and to the point. If you sell something, use this space to describe it in detail and tell us why we should make a purchase. Tap into your creativity. You’ve got this.
“Whatever it is, the way you tell your story online can make .
Our brand vision
Welcome to the frontier of education, where we redefine learning for the digital age.
Our innovative approach blends cutting-edge technology with visionary teaching methodologies to unlock the true potential of every student. Learn more